AI-Powered home device aims to predict COPD attacks before they strike
NCT ID NCT07554352
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study will test a home-monitoring software called RespirAI in 30 adults with COPD who are at high risk for flare-ups. The app uses artificial intelligence to analyze health data and predict when a serious breathing attack might happen. Researchers will compare the app's predictions to actual doctor-confirmed flare-ups to see how accurate and safe it is.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Methodist Physicians Clinic
RECRUITINGOmaha, Nebraska, 68114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may curb antibiotic overuse in COPD attacks
- Can pressurized breathing boost mucus clearance in lung disease?
- HIV and hidden health risks: a major study probes the link
- Smartphone and fitbit data may forecast COPD attacks
- Can tracking early COPD reveal ways to halt its progression?
- Smart inhaler coach: can an app perfect your breathing technique?